Add BrightSurf on Google Email

Synthetic routes to pharmaceuticals greatly expanded leading to new and more effective treatments

A search of the Cambridge Structural Database found nearly 1,800 conglomerate crystal structures with spontaneous enriched chirality, augmenting synthetic building blocks for medicinal chemists. This discovery introduces a new pool of chiral molecules outside of natural sources, potentially leading to more effective treatments.

SourceCCDC - Cambridge Crystallographic Data Centre·JournalJACS Au·TypeData/statistical analysis·DateOct 6, 2022

ProDERM study results of Octagam® 10% treatment in patients with dermatomyositis published in the New England Journal of Medicine

A large randomized clinical trial demonstrated Octagam 10% as an efficacious and well-tolerated treatment option for adult dermatomyositis patients. The study showed improved outcomes in patients with this rare disease, providing a much-needed treatment alternative.

SourceYankee Public Relations·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateOct 6, 2022

Anti-diarrhea medication may help treat core autism symptoms

Researchers used a computer model to identify potential candidates for treating ASD, including loperamide, which has shown promise in restoring social behaviors in genetically engineered mice. The study suggests that repurposing existing drugs like loperamide could provide a new treatment option for core autism symptoms.

SourceFrontiers·JournalFrontiers in Pharmacology·TypeComputational simulation/modeling·DateSep 12, 2022

Research Brief: Study examines how to improve hospitalized patients' access to antimicrobials

The study found that hospitals vary in their stocking practices and often rely on wholesale distributors or neighboring facilities to acquire non-stocked antimicrobials. Researchers recommend improving information sharing and collaboration among local hospitals to reduce barriers to timely treatment.

SourceUniversity of Minnesota Medical School·JournalJournal of the American Pharmacists Association·TypeSurvey·DateSep 8, 2022

Chemotherapy drugs from “rogue” online pharmacies could endanger leukemia patients, suggests research in JNCCN

A study found that a majority of online pharmacies selling imatinib, a chronic myeloid leukemia therapy, are uncertified and operate unsafely. Patients may face risks of nonadherence, treatment failures, and adverse events if they use these pharmacies.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·TypeSystematic review·DateJul 28, 2022

Veterans Health Administration aims to reduce benzodiazepine prescriptions for people 75 and older

A new study within the Veterans Health Administration system identified effective strategies to reduce benzodiazepine prescriptions for older adults. The researchers found that initiatives focusing on passive strategies like education and patient identification have limited success in lowering prescription rates.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateJul 26, 2022

Opioid poisoning on the rise

A study by ETH Zurich researchers shows a sharp increase in opioid poisoning cases and sales in Switzerland between 2000 and 2019, with oxycodone being the second most common cause. The rise is similar to that seen in other European countries, but per capita sales are higher in Switzerland.

SourceETH Zurich·JournalThe Lancet Regional Health - Europe·DateJun 28, 2022

Where the mind is without fear: Scientists discover mechanism behind the chemically induced suppression of fearful memories

Researchers at Tokyo University of Science identify brain regions and signaling pathways involved in fear extinction via delta receptor activation. The study suggests a potential therapeutic agent for post-traumatic stress disorders by suppressing fearful memories.

SourceTokyo University of Science·JournalFrontiers in Behavioral Neuroscience·TypeExperimental study·DateApr 25, 2022

Opioid-related deaths affecting more younger adults, study finds

A new study found that opioid-related mortality rates in Ontario, Canada, have shifted downward to peak in the mid-30s among males and females. The study analyzed high-frequency data from 2003 to 2020 and hypothesizes that opioid-related mortality among younger adults will continue to grow.

SourcePLOS·JournalPLOS ONE·TypeObservational study·DateApr 20, 2022

Global disparities persist in opioid painkiller access

A study led by UCL researchers found significant disparities in opioid painkiller access between countries, with some regions reporting rates as low as 0.01 MME per 1,000/day, while others have surpassed the US in opioid sales. The findings highlight the need for global policies to improve palliative care and pain relief provision.

SourceUniversity College London·JournalThe Lancet Public Health·TypeData/statistical analysis·DateMar 30, 2022

Women who report significant antibiotic use in midlife are more likely to experience cognitive decline in later life, perhaps through gut microbiome changes, in study of almost 15,000 U.S. nurses

A study of nearly 15,000 US nurses found that significant antibiotic use in midlife is associated with increased risk of cognitive decline later in life. The researchers suggest that this may be related to changes in the gut microbiome, which can impact brain function and overall health.

SourcePLOS·JournalPLOS ONE·DateMar 23, 2022

NCCN pharmacy directors forum publishes recommendations for safely dispensing investigational medications for clinical trials

The National Comprehensive Cancer Network has published new consensus recommendations to improve the safety and efficiency of research studies involving investigational drugs. The recommendations focus on seven areas, including pharmacy workflows and collaboration with sponsors.

SourceNational Comprehensive Cancer Network·JournalAmerican Journal of Health-System Pharmacy·DateMar 15, 2022

Southampton-led study shows need for painkiller caution to prevent kidney damage

A recent study led by Dr Simon Fraser from the University of Southampton found that painkiller prescriptions decreased during the pandemic, but high-risk individuals continued to receive them. The research highlights the need for greater caution when prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to prevent kidney damage.

SourceUniversity of Southampton·JournalBJGP Open·TypeMeta-analysis·DateFeb 17, 2022

Novel synthetic process for the core structure of the fungal antiviral agent Neoechinulin B and its derivatives

Researchers have discovered a streamlined two-step synthesis strategy to produce neoechinulin B and its derivatives, exhibiting strong anti-HCV and anti-SARS-CoV-2 activities. The novel process utilizes a piperazine-2,5-dione derivative and tetra-n-butylammonium fluoride (TBAF) as key reagents.

SourceTokyo University of Science·JournalJournal of Natural Products·TypeExperimental study·DateFeb 9, 2022

Inequities in use of diabetes medications

A study of 1.1 million patients with type 2 diabetes found disparities in the use of GLP-1 receptor agonists by racial and ethnic groups, as well as by sex and socioeconomic status. The findings highlight concerns about unequal access to effective diabetes care.

SourceJAMA Network·JournalJAMA Health Forum·DateDec 17, 2021

New research in JNCCN raises concerns about clinical trial bias from undisclosed censoring

A recent study published in JNCCN found that 33 out of 81 studies lacked transparency on censoring, which can introduce bias and affect trial results. The researchers emphasize the need for improved transparency and reporting in clinical trials to ensure patients and clinicians make informed decisions.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateDec 15, 2021

Killing pain without hurting the body: Novel compound that is potentially safer than current drugs

Researchers discover novel compound AD732 with anti-inflammatory and analgesic properties, outperforming standard NSAIDs while causing minimal harm. The compound may be a safer alternative for treating pain and inflammation in difficult diseases like ulcerative colitis and Crohn's disease.

SourceRitsumeikan University·JournalEuropean Journal of Pharmaceutical Sciences·TypeExperimental study·DateDec 14, 2021

Talk therapy by US psychiatrists declined by half since 1990s

A study found that the percentage of psychiatrist visits involving psychotherapy dropped to 21.6% between 1996 and 2016, with rural and Black/Hispanic patients experiencing significant declines. The shift towards medication management is attributed to economic factors and a national shortage in psychiatric services.

SourceColumbia University Irving Medical Center·JournalAmerican Journal of Psychiatry·TypeMeta-analysis·DateDec 8, 2021

Year in pharma: COVID-19 and beyond

The COVID-19 pandemic drove significant advancements in pharmaceutical technology, with mRNA-based vaccines proving highly effective. Oral antiviral pills, such as Merck's molnupiravir and Pfizer's PF-0732133, showed promise in reducing hospitalization and death rates among unvaccinated individuals.

SourceAmerican Chemical Society·JournalChemical & Engineering News·DateDec 8, 2021

Prescribing the abortion pill without restrictions is safe and effective: UBC-led study

A UBC-led study found no increase in abortion-related health complications after Canada removed mifepristone restrictions. The study examined 315,000 abortions in Ontario between 2012 and 2020 and showed that abortion continued to be safe and effective with mifepristone prescribed without restrictions.

SourceUniversity of British Columbia·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateDec 8, 2021

Pharmacy Forecast 2022 anticipates lasting impact from pandemic-related changes to health-system pharmacy

The 2022 Pharmacy Forecast Report notes that COVID-19 disruptions have led to increased roles for pharmacists in patient care, emergency preparedness, and technology. The report also emphasizes the need for equitable access to digital tools and explores strategies to mitigate supply chain issues.

SourceASHP (American Society of Health-System Pharmacists)·JournalAmerican Journal of Health-System Pharmacy·TypeSurvey·DateDec 3, 2021